News To Watch: Facebook Inc (FB) Slam, DaVita HealthCare Partners Inc (DVA) Results, Tripadvisor Inc (TRIP) & Whole Foods Market, Inc. (WFM)

Page 1 of 2

Editor’s Note: Related tickers: Facebook Inc (NASDAQ:FB), DaVita HealthCare Partners Inc (NYSE:DVA), Tripadvisor Inc (NASDAQ:TRIP), Whole Foods Market, Inc. (NASDAQ:WFM), The Walt Disney Company (NYSE:DIS), Electronic Arts Inc. (NASDAQ:EA), McKesson Corporation (NYSE:MCK), Mondelez International Inc (NASDAQ:MDLZ), Symantec Corporation (NASDAQ:SYMC)

Liberal groups slam political ads tied to Facebook CEO (USAToday)
A coalition of liberal and environmental groups announced Tuesday that members would stop advertising on Facebook Inc (NASDAQ:FB) for two weeks to object to the “cynical advertising strategy” of a pro-immigration group linked to Facebook Inc (NASDAQ:FB) founder Mark Zuckerberg. “Leaders in the technology community have every right to talk about how immigration reform will benefit their businesses,” said former senator Russ Feingold, founder of Progressives United. But he accused Zuckerberg’s group of “choosing a strategy that’s condescending to voters and counterproductive to reform.” Nine organizations, including MoveOn.org, the Sierra Club and the League of Conservation Voters, joined the protest.

Facebook Inc (NASDAQ:FB)

Thanks to Strong Revenue, Facebook Inc (NASDAQ:FB) a Fortune 500 company (CrazyJoys)
Today the world’s biggest online social network Facebook Inc (NASDAQ:FB) was announced a position holder at the Fortune 500 list after it went public last year. The company went public in March of 2012 although the initial public offering was massively inflated among unsubstantiated hype. The company could not be able to make its place on Fortune 500 fleet since it took its start in 2004. The reason behind this success is said to be the strong revenue growth that bought Facebook Inc (NASDAQ:FB) its 482nd place on the list. The Facebook success also make its founder and chief executive officer Mark Zuckerberg the youngest executive on the fleet.

DaVita HealthCare Partners Inc. 1st Quarter 2013 Results (WSJ)
DaVita HealthCare Partners Inc (NYSE:DVA) today announced results for the quarter ended March 31, 2013. Adjusted income from continuing operations attributable to DaVita HealthCare Partners Inc (NYSE:DVA) for the three months ended March 31, 2013 was $196.9 million, or $1.84 per share, excluding a loss contingency reserve as further discussed below. Income from continuing operations including this item was $16.9 million, or $0.16 per share. Adjusted income from continuing operations attributable to DaVita HealthCare Partners Inc. for the quarter ended March 31, 2012 was $143.8 million, or $1.50 per share, excluding after-tax transaction expenses associated with the acquisition of HCP of $3.6 million, or $0.04 per share. Income from continuing operations attributable to DaVita HealthCare Partners Inc (NYSE:DVA) for the quarter ended March 31, 2012 including this item was $140.2 million, or $1.46 per share.

US District Court dismisses False Claims Act suit against DaVita (NephrologyNews)
DaVita HealthCare Partners Inc (NYSE:DVA) announced that a False Claims Act suit by a former patient that claimed the dialysis provider violated Medicare regulations by failing to follow the nurse-to-patient ratio of 1:12 has been dismissed. In the suit, former DaVita dialysis patient Laura Turner-Hooks had alleged that the nurses at the DaVita HealthCare Partners Inc (NYSE:DVA) Tel-Huron Dialysis facility in Waterford , Mich., where she received dialysis treatments in 2010, were frequently absent from the floor, according to Law 360. The complaint, which was filed in July 2012 and unsealed in November of that year after the government declined to intervene, also alleged that nurses were also often taking care of 18 patients at a time each.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Click here to Read Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 74 percentage points in 2.5 years. Our beta is only 1.2 (download a FREE newsletter and see the details inside)

Lists

Best Selling Magazines in the World

Shortest People in History

The Most Celebrated Holidays in the World

Most Expensive Handbag Brands in the World

Top Selling Comic Book Issues of this Century

The Most Powerful Women in Politics

Best Paid DJs

Most Rebellious Female Artists

Best Paid TV Actresses of 2014

Best Paid Actors of 2014

Most Expensive Horses in the World

Tallest People Ever

Most Encouraging Feminist Celebrities

Best Paid Supermodels of 2014

Top 10 Suburbs for Retirement in 2015

10 Wealthiest Cities in America

Top 10 TED Talks for Entrepreneurs

Best TED Talks on Education

25 Most Dangerous Places to Live in America

Top 10 Ski Resorts in the United States – 2014 List

Top 10 Most Remote Places in the World

Most Visited Museums in the United States

Wealthiest Photographers in the World

Most Famous Gay Athletes

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!